PHARMACOLOGICAL CHARACTERIZATION OF L-158,809, A NONPEPTIDE ANGIOTENSIN-AT(1) RECEPTOR ANTAGONIST

被引：0
|
作者：
JAISWAL, N [1 ]
KHOSLA, MC [1 ]
机构：
[1] CLEVELAND CLIN FDN, CLEVELAND, OH 44195 USA
来源：
FASEB JOURNAL | 1993年 / 7卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1149 / A1149
页数：1
相关论文
共 50 条
  • [1] INVIVO PHARMACOLOGY OF A HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST - L-158,809
    SIEGL, PKS
    CHANG, RS
    GREENLEE, WJ
    LOTTI, VJ
    MANTLO, NB
    PATCHETT, AA
    SWEET, CS
    FASEB JOURNAL, 1991, 5 (06): : A1576 - A1576
  • [2] INVITRO PHARMACOLOGY OF A HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST - L-158,809
    CHANG, RSL
    SIEGL, PKS
    CLINESCHMIDT, BV
    MANTLO, NB
    CHAKRAVARTY, PK
    GREENLEE, WJ
    PATCHETT, AA
    LOTTI, VJ
    FASEB JOURNAL, 1991, 5 (06): : A1575 - A1575
  • [3] INVIVO PHARMACOLOGY OF L-158,809, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    SIEGL, PKS
    CHANG, RSL
    MANTLO, NB
    CHAKRAVARTY, PK
    ONDEYKA, DL
    GREENLEE, WJ
    PATCHETT, AA
    SWEET, CS
    LOTTI, VJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 139 - 144
  • [4] CHARACTERIZATION OF THE BINDING OF [H-3] L-158,809 - A NEW POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR (AT(1)) ANTAGONIST RADIOLIGAND
    CHEN, TB
    LOTTI, VJ
    CHANG, RSL
    MOLECULAR PHARMACOLOGY, 1992, 42 (06) : 1077 - 1082
  • [5] Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins
    Yuda, A
    Takai, S
    Jin, D
    Sawada, Y
    Nishimoto, M
    Matsuyama, N
    Asada, K
    Kondo, K
    Sasaki, S
    Miyazaki, M
    LIFE SCIENCES, 2000, 68 (01) : 41 - 48
  • [6] DISPOSITION OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST L-158,809 IN RATS AND RHESUS-MONKEYS
    COLLETTI, AE
    KRIETER, PA
    DRUG METABOLISM AND DISPOSITION, 1994, 22 (02) : 183 - 188
  • [7] Angiotensin II receptor antagonist, L-158,809, prevents neointima formation in dog grafted veins
    Yuda, A
    Takai, S
    Jin, D
    Nishimoto, M
    Sawada, Y
    Sasaki, S
    Miyazaki, M
    JOURNAL OF HYPERTENSION, 2000, 18 : S82 - S82
  • [8] ANTIHYPERTENSIVE EFFICACY AND EFFECTS ON RENAL-FUNCTION OF L-158,809 - A NONPEPTIDE ORALLY ACTIVE ANGIOTENSIN-II ANTAGONIST
    KIVLIGHN, SD
    GABEL, RA
    SIEGL, PKS
    HYPERTENSION, 1992, 19 (01) : I135 - I135
  • [9] Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809
    Lear, PM
    Heller, LJ
    Prohaska, JR
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1996, 212 (03): : 284 - 292
  • [10] INVITRO PHARMACOLOGY OF L-158,809, A NEW HIGHLY POTENT AND SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    CHANG, RSL
    SIEGL, PKS
    CLINESCHMIDT, BV
    MANTLO, NB
    CHAKRAVARTY, PK
    GREENLEE, WJ
    PATCHETT, AA
    LOTTI, VJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 133 - 138
12345